Logo image of SER

SERINA THERAPEUTICS INC. (SER) Stock Earnings & Estimates

USA - NYSE Arca - NYSEARCA:SER - US81751A1088 - Common Stock

3.1 USD
+0.41 (+15.24%)
Last: 1/16/2026, 8:04:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
SER revenue by date.SER revenue by date.
30K
-78.57%
142K
373.33%
56K
-60.56%
131.3K
134.46%

-100.00%
27.773M
EBITDA
YoY % growth
SER ebitda by date.SER ebitda by date.
-6.85M
13.40%
-9.829M
-43.49%
-16.854M
-71.47%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
SER ebit by date.SER ebit by date.
-6.98M
13.18%
-9.96M
-42.69%
-17.048M
-71.16%
-23.351M
-36.97%
-30.458M
-30.43%
-34.066M
-11.85%
-42.567M
-24.95%
-49.999M
-17.46%
-42.932M
14.13%
-13.252M
69.13%
-13.172M
0.60%
5.286M
140.13%
Operating Margin
SER operating margin by date.SER operating margin by date.
-23,266.67%-7,014.08%-30,442.86%-17,784.62%N/AN/AN/AN/AN/AN/AN/A19.03%
EPS
YoY % growth
SER eps by date.SER eps by date.
N/AN/AN/A-2.03-1.82
10.20%
-1.41
22.44%
-1.21
14.29%
-1.26
-4.17%
-1.14
9.60%
-1.16
-1.77%
-1.43
-23.48%
-1.08
24.65%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.45
8.28%
-0.46
30.37%
-0.46
8.90%
-0.45
-66.46%
Revenue
Q2Q % growth

-100.00%

100.00%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-7.394M
-26.22%
-7.627M
-37.04%
-7.74M
-38.87%
-7.856M
-29.61%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
-0.27 -0.460.1941.89%
Q3 2025
Q2Q % growth
-0.51 -0.540.034.73%
Q2 2025
Q2Q % growth
-0.66 -0.43-0.23-53.76%
Q1 2025
Q2Q % growth
-0.49 -0.630.1421.75%
SER Yearly EPS VS EstimatesSER Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 -0.5 -1 -1.5 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth

-100.00%
%
Q2 2025
Q2Q % growth
130K
154.90%
130K%
Q1 2025
Q2Q % growth

-100.00%
%
Q3 2024
Q2Q % growth
14K
-80.00%
%
Q2 2024
Q2Q % growth
51K
410.00%
%
Q1 2024
Q2Q % growth
5K
-50.00%
%
Q4 2023
Q2Q % growth
56K
460.00%
%
Q3 2023
Q2Q % growth
70K
600.00%
%
Q2 2023
Q2Q % growth
10K %
Q1 2023
Q2Q % growth
10K %
Q4 2022
Q2Q % growth
10K
-66.67%
%
Q3 2022
Q2Q % growth
10K
-50.00%
%
Q2 2022
Q2Q % growth
10K
-75.00%
%
Q1 2022
Q2Q % growth
10K
-83.33%
%
Q4 2021
Q2Q % growth
30K
-81.25%
%
Q3 2021
Q2Q % growth
20K
-71.43%
%
Q2 2021
Q2Q % growth
40K
-20.00%
%
Q1 2021
Q2Q % growth
60K
-33.33%
%
SER Yearly Revenue VS EstimatesSER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2033 5M 10M 15M 20M 25M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 5.63% 5.63%
RevenueN/A N/A 0% 0%